157 related articles for article (PubMed ID: 38696372)
1. Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.
Tan N; Ngu N; Worland T; Lee T; Abrahams T; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson AJ; Ding JN; Nicoll AJ; Liu K; Pandya K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38696372
[TBL] [Abstract][Full Text] [Related]
2. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
3. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
4. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
Nair AV; Macdonald DB; Kelly EM; Satheesh S; Venugopalan P; Soman DK
Clin Imaging; 2022 Jan; 81():47-53. PubMed ID: 34598005
[TBL] [Abstract][Full Text] [Related]
5. The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.
Segal D; Marotta P; Mosli M; Zou G; Feagan BG; Al-Judaibi B
Saudi J Gastroenterol; 2019; 25(3):152-158. PubMed ID: 31044745
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging features of small-duct primary sclerosing cholangitis.
Kozaka K; Sheedy SP; Eaton JE; Venkatesh SK; Heiken JP
Abdom Radiol (NY); 2020 Aug; 45(8):2388-2399. PubMed ID: 32417935
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
[TBL] [Abstract][Full Text] [Related]
8. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
[No Abstract] [Full Text] [Related]
9. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
[TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
[TBL] [Abstract][Full Text] [Related]
11. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Zenouzi R; Liwinski T; Yamamura J; Weiler-Normann C; Sebode M; Keller S; Lohse AW; Schramm C;
Aliment Pharmacol Ther; 2018 Jul; 48(2):169-178. PubMed ID: 29741240
[TBL] [Abstract][Full Text] [Related]
12. Differentiating pediatric autoimmune liver diseases by quantitative magnetic resonance cholangiopancreatography.
Gilligan LA; Trout AT; Lam S; Singh R; Tkach JA; Serai SD; Miethke AG; Dillman JR
Abdom Radiol (NY); 2020 Jan; 45(1):168-176. PubMed ID: 31422438
[TBL] [Abstract][Full Text] [Related]
13. Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis.
Eaton JE; Welle CL; Bakhshi Z; Sheedy SP; Idilman IS; Gores GJ; Rosen CB; Heimbach JK; Taner T; Harnois DM; Lindor KD; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
Hepatology; 2021 May; 73(5):1868-1881. PubMed ID: 32974892
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography.
Textor HJ; Flacke S; Pauleit D; Keller E; Neubrand M; Terjung B; Gieseke J; Scheurlen C; Sauerbruch T; Schild HH
Endoscopy; 2002 Dec; 34(12):984-90. PubMed ID: 12471543
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study.
Poetter-Lang S; Messner A; Bastati N; Ringe KI; Ronot M; Venkatesh SK; Ambros R; Kristic A; Korajac A; Dovjak G; Zalaudek M; Hodge JC; Schramm C; Halilbasic E; Trauner M; Ba-Ssalamah A
Eur Radiol; 2023 Dec; 33(12):9022-9037. PubMed ID: 37470827
[TBL] [Abstract][Full Text] [Related]
16. Correlation between findings on MRCP and gadolinium-enhanced MR of the liver and a survival model for primary sclerosing cholangitis.
Petrovic BD; Nikolaidis P; Hammond NA; Martin JA; Petrovic PV; Desai PM; Miller FH
Dig Dis Sci; 2007 Dec; 52(12):3499-506. PubMed ID: 17410447
[TBL] [Abstract][Full Text] [Related]
17. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
18. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Bowlus CL; Lim JK; Lindor KD
Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2416-2422. PubMed ID: 31306801
[TBL] [Abstract][Full Text] [Related]
19. Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI.
Kim JH; Byun JH; Kim SY; Lee SS; Kim HJ; Kim MH; Lee MG
Acta Radiol; 2013 Jul; 54(6):601-7. PubMed ID: 23528564
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study.
Tan N; Ngu N; Worland T; Lee T; Abrahams T; Pandya K; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson A; Ding J; Nicoll AJ; Liu K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A;
Hepatol Int; 2022 Oct; 16(5):1094-1104. PubMed ID: 35657479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
